Pharmacological basis for combination therapy of hypertension.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008914:Minoxidil / Q000008:administration & dosage / Q000627:therapeutic use; D010349:Patient Compliance; D012110:Reserpine / Q000008:administration & dosage / Q000627:therapeutic use; D013565:Sympatholytics / Q000008:administration & dosage / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D004338:Drug Combinations; D013565:Sympatholytics; D014665:Vasodilator Agents; D006830:Hydralazine; D008914:Minoxidil; D012110:Reserpine